| Disease | Modulation | Upregulated | Downregulated | References |
| Steatosis/NASH | Pri-miR-26a-1 (in NASH), miR-122, miR-370, miR-34a, miR-16, miR-33a/b, miR-200a/b, miR-429, miR-221, miR-155, miR-181a, miR-10b, let-7b (in NASH), miR-199a (in NASH) | miR-99a/b, miR-21, miR-29c, miR-451, let-7d (in NASH), miR-199a (in steatosis), miR-128-2 | [31, 35, 36, 38–40, 43, 45, 46, 52–55, 60, 65, 67, 68, 71, 76, 77, 98, 102, 109] |
| Fibrosis | miR-122, miR-34a, miR-199a/a*, miR-200a/b, miR-21, miR-221/222, miR-155, let-7e | miR-16, miR-15b, miR-99b, miR-197, miR-29 | [31, 39, 45, 55, 66, 72, 82, 86, 87] |
| Cirrhosis | miR-34a, miR-21, miR-31, miR-122, miR-221, miR-155, miR-181b | miR-29 | [30, 31, 85, 86, 91–93] |
| HCC | miR-122 (serum), miR-16, miR-33, miR-21, miR-31, miR-221/222, miR-155, miR-181a/b, let-7a/b, miR-10b | miR-122 (tissue), miR-34a, miR-200a/b, miR-99a, let-7c/g, miR-199a/b-3p | [29, 33, 40, 47, 48, 50, 51, 56, 57, 62, 65, 70, 73–75, 78, 81, 83–85, 88–92, 94–97, 99, 103, 105, 106] |
|
|